Evaluation of the adverse event of nimotuzumab combined therapy in patients with advanced carcinoma.
L. Chen
No relevant relationships to disclose
H. Chen
No relevant relationships to disclose
X. Zhang
No relevant relationships to disclose
B. Liang
No relevant relationships to disclose
G. Zhang
No relevant relationships to disclose
G. MA
No relevant relationships to disclose
J. Zheng
No relevant relationships to disclose